GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novogene Co Ltd (SHSE:688315) » Definitions » Price-to-Operating-Cash-Flow

Novogene Co (SHSE:688315) Price-to-Operating-Cash-Flow : 16.09 (As of Jun. 26, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Novogene Co Price-to-Operating-Cash-Flow?

As of today (2025-06-26), Novogene Co's share price is ¥13.58. Novogene Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.84. Hence, Novogene Co's Price-to-Operating-Cash-Flow Ratio for today is 16.09.

The historical rank and industry rank for Novogene Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:688315' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.25   Med: 30.18   Max: 66.68
Current: 16.1

During the past 10 years, Novogene Co's highest Price-to-Operating-Cash-Flow Ratio was 66.68. The lowest was 12.25. And the median was 30.18.

SHSE:688315's Price-to-Operating-Cash-Flow is ranked better than
65.03% of 306 companies
in the Biotechnology industry
Industry Median: 25.095 vs SHSE:688315: 16.10

Novogene Co's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ¥-0.35. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.84.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novogene Co was 40.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.30% per year.

During the past 10 years, Novogene Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 84.10% per year. The lowest was -33.90% per year. And the median was 14.50% per year.


Novogene Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Novogene Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novogene Co Price-to-Operating-Cash-Flow Chart

Novogene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 54.63 34.95 28.26 13.30

Novogene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.49 17.81 16.12 13.30 17.80

Competitive Comparison of Novogene Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Novogene Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novogene Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novogene Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novogene Co's Price-to-Operating-Cash-Flow falls into.


;
;

Novogene Co Price-to-Operating-Cash-Flow Calculation

Novogene Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=13.58/0.844
=16.09

Novogene Co's Share Price of today is ¥13.58.
Novogene Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Novogene Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Novogene Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Novogene Co Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Shengshengyuan Road, Room B258, Innovation Building, Huilongguan Town, Changping District, Beijing, CHN, 100015
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.

Novogene Co Headlines

No Headlines